APTEVO THERAPEUTICS INC.— Sankey Diagram

Annual mode · period ending 2025-12-31 · SEC EDGAR

FY2022 - Q4(Oct 22 · Nov 22 · Dec 22)
Total Assets
$27M
↑+74.4% +$12Mvs FY2024
Total Liabilities
$10M
↓-9.4% -$1Mvs FY2024
Equity
$17M
↑+265.5% +$13Mvs FY2024
Cash
$22M
↑+148.1% +$13Mvs FY2024
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
Reconciled values per the annual mode pipeline. Compare against SEC EDGAR filings.
Line itemFY2025FY2024
Total Assets$27M$16M
Current Assets$23M$11M
Cash$22M$9M
ST Investments$0$0
Receivables$0$0
Inventory$0$0
Other Current$1M$2M
Non-Current Assets$4M$5M
PPE$303K$543K
Goodwill$0$0
Intangibles$0$0
Investments$0$0
Other Non-Current$4M$4M
Total Liab+Eq$27M$16M
Current Liab.$6M$6M
Accounts Payable$877K$1M
Short-Term Debt$0$0
Deferred Revenue$0$0
Other CL$5M$5M
Non-Current Liab.$4M$5M
Long-Term Debt$0$0
Other LT Liab.$4M$5M
Equity$17M$5M
Retained Earnings$275M$248M
Other Equity$0$0

QuarterCharts · SEC EDGAR data · APVO · Comparing FY2025 vs FY2024